Psychological Mobile Interventions to Reduce Distress

February 5, 2025 updated by: Sîrbu Vasile, Babes-Bolyai University

Effectiveness and Mechanisms of Change of Two Mobile Psychological Interventions in Reducing Depressive, Anxiety and Stress Symptoms: PsyPills and Online-Contingent Attention Training (OCAT)

Investigating the effectiveness of two mobile psychological interventions and the mechanisms of change involved in reducing the symptoms of depression, anxiety and stress, on an adult population with a mild to moderate level of symptoms (sub-clinical).

Study Overview

Detailed Description

The research design will be a 3-arm controlled clinical trial, with 4 waves of data collection. Once selected using a symptomatic screening questionnaire, participants will be randomly assigned to one of three conditions: 2 experimental conditions (PsyPills and OCAT) and an active control group (shamOCAT).

Measurements will be collected before allocation (baseline), during the intervention (through a momentary ecological assessment paradigm), at the end (post) and at an interval of one month after the intervention (follow-up). Among the constructs evaluated are symptomatic level, affectivity, cognitive processes, emotional regulation and attentional bias. All measurement steps will be collected online.

The interventions consist of an attentional training (Online-Contingent Attention Training, OCAT) which seeks to facilitate the disengagement from the negative content and the engagement on the positive of some personally relevant information by providing instructions and feedback on performance; and prescribing personalized rational thinking strategies to change the intensity of dysfunctional emotionality (PsyPills). The active control group consists of a "fake" version of OCAT (shamOCAT), by offering the same attentional training, without training and feedback on performance. All interventions are delivered in the form of smartphone applications.

Study Type

Interventional

Enrollment (Actual)

450

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cluj-Napoca, Romania, 400084
        • Babes-Bolyai University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18-65 years old
  • Have access and able to use a smartphone

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PsyPills
The participants randomized in this condition will receive the mobile health application "PsyPills".
Prescribing personalized rational thinking strategies to change levels of dysfunctional emotionality.
Experimental: OCAT
The participants randomized in this condition will receive the mobile health application "OCAT".
Facilitating the disengagement from negative content and engagement of positive one of personally relevant information by providing instruction and feedback on performance.
Placebo Comparator: OCAT sham
The active control group, which consists of the "fake" version of the OCAT intervention, by offering the same attentional training, without training and feedback on performance.
The active control group, which consists of the "fake" version of the OCAT intervention, by offering the same attentional training, without training and feedback on performance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive, Anxiety, and Stress Symptoms
Time Frame: Baseline
DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes
Baseline
Change from Baseline Depressive, Anxiety, and Stress Symptoms at 5 days
Time Frame: Mid of intervention (5 days)
DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes
Mid of intervention (5 days)
Change from Baseline Depressive, Anxiety, and Stress Symptoms at 10 days
Time Frame: Post intervention (10 day)
DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes
Post intervention (10 day)
Change from Baseline Depressive, Anxiety, and Stress Symptoms at 1 month
Time Frame: Follow-up (1 month)
DASS-21, with scores from 0 to 63, higher scores meaning worse outcomes
Follow-up (1 month)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Reappraisal
Time Frame: Baseline
Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes
Baseline
Change from Baseline Functional Reappraisal at 5 days
Time Frame: Mid of intervention (5 days)
Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes
Mid of intervention (5 days)
Change from Baseline Functional Reappraisal at 10 days
Time Frame: Post intervention (10 day)
Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes
Post intervention (10 day)
Change from Baseline Functional Reappraisal at 1 month
Time Frame: Follow-up (1 month)
Acceptance, Putting into perspective and inversed scores of Catastrophizing subscales of CERQ-SF, with scores from 6 to 30, higher scores meaning better outcomes
Follow-up (1 month)
Positive Reappraisal
Time Frame: Baseline
Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes
Baseline
Change from Baseline Positive Reappraisal at 5 days
Time Frame: Mid of intervention (5 days)
Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes
Mid of intervention (5 days)
Change from Baseline Positive Reappraisal at 10 days
Time Frame: Post intervention (10 days)
Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes
Post intervention (10 days)
Change from Baseline Positive Reappraisal at 1 month
Time Frame: Follow-up (1 month)
Positive reappraisal subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning better outcomes
Follow-up (1 month)
Rational and Irrational Beliefs
Time Frame: Baseline
HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes
Baseline
Change from Baseline Rational and Irrational Beliefs at 5 days
Time Frame: Mid of intervention (5 days)
HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes
Mid of intervention (5 days)
Change from Baseline Rational and Irrational Beliefs at 10 days
Time Frame: Post intervention (10 days)
HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes
Post intervention (10 days)
Change from Baseline Rational and Irrational Beliefs at 1 month
Time Frame: Follow-up (1 month)
HABS-AV, with scores from 24 to 120, with higher scores meaning worse outcomes
Follow-up (1 month)
Rumination
Time Frame: Baseline
Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes
Baseline
Change from Baseline Rumination at 5 days
Time Frame: Mid of intervention (5 days)
Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes
Mid of intervention (5 days)
Change from Baseline Rumination at 10 days
Time Frame: Post intervention (10 days)
Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes
Post intervention (10 days)
Change from Baseline Rumination at 1 month
Time Frame: Follow-up (1 month)
Focus on thought/rumination subscale of CERQ-SF, with scores from 2 to 10, higher scores meaning worse outcomes
Follow-up (1 month)
Functional and Dysfunctional Emotions
Time Frame: Baseline
PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes
Baseline
Change from Baseline Functional and Dysfunctional Emotions at 5 days
Time Frame: Mid of intervention (5 days)
PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes
Mid of intervention (5 days)
Change from Baseline Functional and Dysfunctional Emotions at 10 days
Time Frame: Post intervention (10 days)
PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes
Post intervention (10 days)
Change from Baseline Functional and Dysfunctional Emotions at 1 month
Time Frame: Follow-up (1 month)
PAD, functional emotions subscale, with scores from 12 to 60, and dysfunctional emotions subscale, with scores from 14 to 70, with higher scores meaning worse outcomes
Follow-up (1 month)
Attention bias
Time Frame: Baseline
Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words
Baseline
Change from Baseline Attention Bias at 5 days
Time Frame: Mid of intervention (5 days)
Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words
Mid of intervention (5 days)
Change from Baseline Attention Bias at 10 days
Time Frame: Post intervention (10 days)
Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words
Post intervention (10 days)
Change from Baseline Attention Bias at 1 month
Time Frame: Follow-up (1 month)
Engagement in positive information and inhibition of negative information web measures with an index of attention bias for processing positive vs. negative material computed by dividing the total fixation time on positive words by the total fixation time on emotional (positive and negative) words
Follow-up (1 month)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experience Sampling Methods (ESM) questionnaire
Time Frame: During the intervention (3 times daily from day 1 to day 10)
Items selected from the main scales, including 8 items for rational/irrational beliefs, 9 affective state items, 5 items from the subscales of interest of CERQ-SF, on a visual analog scale (VAS) format; the direction of scores is the same with those of the original scales and subscales from which th items are taken from
During the intervention (3 times daily from day 1 to day 10)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Oana David, Dr., Babes-Bolyai University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2022

Primary Completion (Actual)

October 29, 2023

Study Completion (Actual)

October 29, 2023

Study Registration Dates

First Submitted

February 23, 2022

First Submitted That Met QC Criteria

March 15, 2022

First Posted (Actual)

March 24, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 5, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Distress

Clinical Trials on PsyPills

Subscribe